• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如果看起来没什么问题,一切就都正常吗?一种在没有金标准时评估内镜检查诊断价值的简单方法。

Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent.

作者信息

Schneeweiss S, Kriegmair M, Stepp H

机构信息

Department of Epidemiology, Harvard University School of Public Health, Boston, Massachusetts, USA.

出版信息

J Urol. 1999 Apr;161(4):1116-9.

PMID:10081850
Abstract

PURPOSE

We demonstrate a simple yet comprehensive method to evaluate the sensitivity of endoscopic procedures when no gold standard is available.

MATERIALS AND METHODS

In 208 consecutive patients with superficial bladder cancer 328 endoscopies were performed to compare the sensitivity of white light and 5-aminolevulinic acid induced fluorescence endoscopy. Both procedures were performed during the same session.

RESULTS

The maximum interval of observable sensitivity for 5-aminolevulinic acid induced fluorescence endoscopy ranged between 78 and 97.5%, and the best estimate for sensitivity based on realistic assumptions was 93.4% (95% confidence intervals 90 to 97.3). The best sensitivity estimate for white light endoscopy was 46.7% (95% confidence intervals 39.4 to 54.3, maximum range 47.2 to 53%).

CONCLUSIONS

This method to determine the maximum possible range of sensitivity estimates for endoscopic procedures without a gold standard is easily applied. Depending on the assumptions a range of reasonable scenarios can be constructed and the corresponding sensitivities can be reported. This approach gives fast and valid results, and could further indicate the diagnostic superiority of 5-aminolevulinic acid induced fluorescence compared to white light endoscopy.

摘要

目的

我们展示了一种简单而全面的方法,用于在没有金标准的情况下评估内镜检查程序的敏感性。

材料与方法

对208例连续性浅表性膀胱癌患者进行了328次内镜检查,以比较白光内镜和5-氨基乙酰丙酸诱导荧光内镜的敏感性。两种检查均在同一次检查中进行。

结果

5-氨基乙酰丙酸诱导荧光内镜可观察到的敏感性最大区间为78%至97.5%,基于实际假设的敏感性最佳估计值为93.4%(95%置信区间90%至97.3%)。白光内镜的最佳敏感性估计值为46.7%(95%置信区间39.4%至54.3%,最大范围47.2%至53%)。

结论

这种在没有金标准的情况下确定内镜检查程序敏感性估计最大可能范围的方法易于应用。根据假设,可以构建一系列合理的情况并报告相应的敏感性。这种方法能快速得出有效结果,并可进一步表明5-氨基乙酰丙酸诱导荧光与白光内镜相比的诊断优势。

相似文献

1
Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent.如果看起来没什么问题,一切就都正常吗?一种在没有金标准时评估内镜检查诊断价值的简单方法。
J Urol. 1999 Apr;161(4):1116-9.
2
Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.使用5-氨基酮戊酸诱导荧光内镜与白光内镜进行经尿道膀胱癌切除术的比较。
J Urol. 2002 Aug;168(2):475-8.
3
Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.5-氨基乙酰丙酸诱导荧光的定量分析提高了膀胱癌检测的特异性。
J Urol. 2001 Nov;166(5):1665-8; discussion 1668-9.
4
Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.5-氨基酮戊酸诱导荧光诊断对浅表性膀胱肿瘤患者无复发生存率的临床相关改善
J Urol. 2002 Jul;168(1):67-71.
5
Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.使用六氨基乙酰丙酸成像改善膀胱癌的检测和治疗:一项前瞻性III期多中心研究。
J Urol. 2005 Sep;174(3):862-6; discussion 866. doi: 10.1097/01.ju.0000169257.19841.2a.
6
Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.通过5-氨基乙酰丙酸诱导的卟啉荧光检测早期膀胱癌
J Urol. 1996 Jan;155(1):105-9; discussion 109-10.
7
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.5-氨基酮戊酸用于检测膀胱移行细胞癌的七年经验
Urology. 2007 Feb;69(2):260-4. doi: 10.1016/j.urology.2006.10.015.
8
[The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].[5-氨基酮戊酸(ALA)荧光检测对浅表性膀胱癌预后的影响]
Aktuelle Urol. 2004 Nov;35(6):497-501. doi: 10.1055/s-2004-818544.
9
Sensitivity analysis of the diagnostic value of endoscopies in cross-sectional studies in the absence of a gold standard.在缺乏金标准的情况下,横断面研究中内镜检查诊断价值的敏感性分析。
Int J Technol Assess Health Care. 2000 Summer;16(3):834-41. doi: 10.1017/s0266462300102107.
10
Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?六氨基乙酰丙酸诱导荧光辅助的柔性膀胱镜检查:膀胱癌检测和监测的新方法?
Eur Urol. 2005 Mar;47(3):323-6. doi: 10.1016/j.eururo.2004.10.025. Epub 2004 Dec 30.

引用本文的文献

1
Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis.窄带成像(NBI)和光动力诊断(PDD)荧光成像与白光膀胱镜检查(WLC)在检测非肌肉浸润性膀胱癌中的性能比较:一项系统评价和病变水平诊断性荟萃分析。
Cancers (Basel). 2021 Aug 30;13(17):4378. doi: 10.3390/cancers13174378.
2
Blue Light Cystoscopy: Indications and Outcomes.蓝激光膀胱镜检查:适应证和结果。
Curr Urol Rep. 2020 Apr 4;21(5):19. doi: 10.1007/s11934-020-0966-5.
3
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin.
经卡介苗膀胱内灌注后非肌层浸润性膀胱癌的膀胱保留治疗疗效的系统评价
Eur Urol. 2020 Sep;78(3):387-399. doi: 10.1016/j.eururo.2020.02.012. Epub 2020 Mar 4.
4
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.蓝激光光动力膀胱镜检查联合氨基酮戊酸治疗非肌层浸润性膀胱癌:美国临床证据综述和最佳使用共识声明——2018 更新版。
Nat Rev Urol. 2019 Jun;16(6):377-386. doi: 10.1038/s41585-019-0184-4.
5
Nuclear Matrix Protein 22 in Voided Urine Cytology Efficacy in Risk Stratification for Carcinoma of Bladder.核基质蛋白22在膀胱冲洗液细胞学检查中对膀胱癌风险分层的有效性
World J Oncol. 2013 Jun;4(3):151-157. doi: 10.4021/wjon677w. Epub 2013 Jul 15.
6
Review of the Clinical Approaches to the Use of Urine-based Tumor Markers in Bladder Cancer.膀胱癌中基于尿液的肿瘤标志物临床应用方法综述。
Rambam Maimonides Med J. 2017 Oct 16;8(4):e0040. doi: 10.5041/RMMJ.10314.
7
Urinary mRNA biomarker panel for the detection of urothelial carcinoma.用于检测尿路上皮癌的尿液mRNA生物标志物组合
Oncotarget. 2016 Jun 21;7(25):38731-38740. doi: 10.18632/oncotarget.9587.
8
Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.通过检测尿液中酪氨酸磷酸化蛋白实现膀胱癌的早期诊断。
Br J Cancer. 2015 Jul 28;113(3):469-75. doi: 10.1038/bjc.2015.232. Epub 2015 Jun 30.
9
Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?UroVysion荧光原位杂交检测在膀胱癌患者监测中的作用的多中心评估:荧光原位杂交阳性是否预示复发?
World J Urol. 2015 Sep;33(9):1309-13. doi: 10.1007/s00345-014-1452-9. Epub 2014 Nov 25.
10
Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.联合检测 Mcm5 和核基质蛋白 22 对膀胱癌的诊断和临床意义疾病的识别。
PLoS One. 2012;7(7):e40305. doi: 10.1371/journal.pone.0040305. Epub 2012 Jul 9.